Although the COVID-19 pandemic hampered the US diabetes care device market in 2020, rising demand for remote monitoring and telehealth services spurred increased glucose monitoring device sales during this period. Beyond the pandemic, moderate growth is anticipated over the forecast period, driven by favorable demographics and the adoption of advanced products—such as hybrid closed-loop insulin pumps—that command a premium price. The opportunities presented in the diabetes care device market are encouraging companies to invest in R&D and to partner with digital technology companies to develop new products that provide treatment improvements for patients.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for diabetes care devices in the US from 2019 through 2031.
The COVID-19 pandemic has had minimal impact on the diabetes care device market.
To what extent has the COVID-19 pandemic impacted the diabetes care device market in the US?
How is recovery varying by segment?
When will the market exhibit pre-pandemic growth?
The US diabetes care device market will grow strongly through 2031.
How will growth vary between product segments?
What are the factors driving market expansion?
Numerous new competitors are expected to enter this space within the forecast period.
Who are these competitors and what products are they bringing to the market?
Which segments are seeing the most incoming competitors?
The insulin delivery device market is large and will continue to expand rapidly.
What are new innovations are emerging in this segment?
What factors are driving growth in this market?
Which types of devices are seeing the strongest adoption, and how are these trends affecting other product segments?
Several products within the diabetes care device space have gained Medicare coverage in recent years.
Which products and companies have benefited from this?
What other companies are also seeking to gain coverage approval from CMS?
- Diabetes Care Devices - Market Insights - United States
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Diabetes Care Device Market, by Product Type, US (USD), 2019u20132031
- Diabetes Care Device Market Landscape, US (USD), 2021 and 2031
- Competitive Highlights
- Diabetes Care Device Market Leaders, by Product Type and Revenue, US, 2021
- Competitive Insights
- Companies Mentioned
- Market Developments
- u200bRecent Events in the Diabetes Care Device Market, US
- Emerging Products for the Diabetes Care Device Market, US
- Products Covered
- Diabetes Care Devices Covered, US
- Key Report Updates
- COVID-19 Analysis
- Market Impact
- COVID-19 Impact Assessment Summary, Diabetes Care Device Market, US
- Major Market Forecast Changes and Assumptions
- Diabetes Care Device Market, by Product Type, US (USD), 2019u20132030 (Excluding COVID-19 Impact)
- Diabetes Care Device Market, by Product Type, US (USD), 2019u20132031 (Including COVID-19 Impact)
- Competitive Impact
- COVID-19 Competitive Factors and Strategies, Diabetes Care Device Market, US
- COVID-19 Financial Impact and Competitor Insights
- Diabetes Care Device Market
- Market Highlights
- Key Content Updates
- US Diabetes Care Device Market Drivers
- US Diabetes Care Device Market Limiters
- Diabetes Care Device Market, by Product Type, US (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Diagnosed Prevalent Drug-Treated Diabetes Patients, by Disease Type, US, 2019u20132031
- Diabetes Care Device Market, by Product Type, US (USD), 2019u20132031
- Market Shares
- Diabetes Care Device Revenue Market Shares, US, 2021
- Diabetes Care Device Revenue Market Shares, by Product Type, US, 2021
- Competitive Insights
- Novo Nordisk Competitive Insights
- Eli Lilly Competitive Insights
- Sanofi Competitive Insights
- Medtronic Competitive Insights
- Competitive Insights for Other Key Competitors
- Market Developments
- u200bRecent Events in the Diabetes Care Device Market, US
- Emerging Products for the Diabetes Care Device Market, US
- Glucose Monitoring Device Market
- Market Highlights
- Key Content Updates
- US Glucose Monitoring Device Market Drivers
- US Glucose Monitoring Device Market Limiters
- Glucose Monitoring Device Market, by Product Type, US (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Glucose Monitoring Device Market, by Product Type, US (USD), 2019u20132031
- SMBG Device Market, by Product Type, US (USD), 2019u20132031
- SMBG Device Market Growth, by Product Type, US, 2020u20132031
- CGM Device Market, by Product Type, US (USD), 2019u20132031
- CGM Device Market Growth, by Product Type, US, 2020u20132031
- Market Shares
- Glucose Monitoring Device Revenue Market Shares, US, 2021
- Glucose Monitoring Device Revenue Market Shares, by Product Type, US, 2021
- Competitive Insights
- Insulin Delivery Device Market
- Market Highlights
- Key Content Updates
- US Insulin Delivery Device Market Drivers
- US Insulin Delivery Device Market Limiters
- Insulin Delivery Device Market, by Product Type, US (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Diagnosed Prevalent Diabetes Patients, by Treatment Type, US, 2019u20132031
- Insulin Delivery Device Market, by Product Type, US (USD), 2019u20132031
- MDI Device Market, by Product Type, US (USD), 2019u20132031
- Insulin Syringe Market, US (USD), 2019u20132031
- Insulin Pen and Accessory Market, by Product Type, US (USD), 2019u20132031
- Insulin Pen and Accessory Market Growth, by Product Type, US, 2020u20132031
- Insulin Pump Patients, by Product Type, US, 2019u20132031
- Insulin Pump Market, by Product Type, US (USD), 2019u20132031
- Conventional Pump Market, by Product Type, US (USD), 2019u20132031
- Conventional Pump Market Growth, by Product Type, US, 2020u20132031
- Patch Pump Market, by Product Type, US (USD), 2019u20132031
- Patch Pump Market Growth, by Product Type, US, 2020u20132031
- Market Shares
- Insulin Delivery Device Revenue Market Shares, US, 2021
- Insulin Delivery Device Revenue Market Shares, by Product Type, US, 2021
- Competitive Insights
- Appendix
- Abbreviations
- Bibliography
Suchitra Ghoshal
Suchitra Ghoshal is an associate healthcare research & data analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Clarivate, specializing in the biosurgical agent market. Suchitra holds a Bachelor’s degree in Life Sciences from Delhi University, and a Master’s degree in Environmental Science from Guru Gobind Singh Indraprastha University, New Delhi.